In November 2022, the FDA inspected Intas’ factory in Ahmedabad, India, and found acid poured on drug quality control documents and torn reports stuffed in bags, which were placed under a stairwell, in a scrap room and in a truck on the facility’s campus. In response, the agency halted some production and imports.
By early 2023, cisplatin, carboplatin and a few other popular cancer drugs were in short supply. The shortages have hindered care at cancer centers and hospitals across the country as clinicians rationed supply, but the shortages began easing in the fall.
Accord has resumed manufacturing batches of two cisplatin solutions, according to a Nov. 13 update in the FDA’s drug shortage database.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
